Showing results (1-10 of 305) with videos related to
Sort By:
Pageof 31
Muscle & Nerve|October 19, 2011
MG-ADL: still a relevant outcome measureSrikanth Muppidi, Gil I Wolfe, Mark Conaway, et al.Frontiers of Neurology and Neuroscience|April 8, 2009
Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravisSrikanth Muppidi, Gil I WolfeJournal of the Neurological Sciences|July 28, 2024
Psychometric properties of MG-ADL items and MG-ADL score: An assessment of distributional characteristics, validity and factor structure in two large datasetsMathieu F Janssen, Sarah Dewilde, Gil I Wolfe, et al.Neurology|May 5, 2010
The MG Composite: A valid and reliable outcome measure for myasthenia gravisTed M Burns, Mark Conaway, Donald B Sanders, et al.Journal of Clinical Neuromuscular Disease|September 3, 2010
Isolated neck extensor myopathy: is it responsive to immunotherapy?Srikanth Muppidi, David S Saperstein, Aziz Shaibani, et al.Muscle & Nerve|May 15, 2012
Psychometric evaluation of the myasthenia gravis composite using Rasch analysisReza Sadjadi, Mark Conaway, Gary Cutter, et al.Annals of the New York Academy of Sciences|December 21, 2012
The myasthenia gravis--specific activities of daily living profileSrikanth MuppidiMuscle & Nerve|November 18, 2010
The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravisTed M Burns, C K Grouse, Gil I Wolfe, et al.Journal of Clinical Neuromuscular Disease|February 22, 2017
Outcome Measures in Myasthenia Gravis: Incorporation Into Clinical PracticeSrikanth MuppidiContinuum (Minneapolis, Minn.)|October 10, 2014
Paraneoplastic neuropathiesSrikanth Muppidi, Steven VerninoPageof 31